# CATHOLIC UNIVERSITY OF AMERICA: Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure

**Lab Budget Score:** 25/100

| Field | Value |
|---|---|
| Organization | CATHOLIC UNIVERSITY OF AMERICA |
| Location | WASHINGTON, DC |
| Project | Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure |
| Project number | 3DP1DA060580-03S1 |
| Mechanism | DP1 |
| Institute | National Institute on Drug Abuse |
| Award | $94,756 |
| Awarded | 2026-09-14 |
| Project period | 2024-06-01 to 2029-03-31 |
| UEI | C31ES3WEAVQ5 |

## Why this score
- Award of $94,756.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11536322). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.